Back to 
Schroder Investment Management Group
Schroder Investment Management Group
FATE
Showing 0 of 14 quarters
Position history for Schroder Investment Management Group's holdings in Fate Therapeutics, Inc.
No. Schroder Investment Management Group exited its FATE (Fate Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 137,341 shares worth $1.4M. Schroder Investment Management Group first reported FATE in Q4 2019 and held it in 13 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.